Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1963 1
1965 2
1966 1
1968 4
1969 1
1970 2
1971 1
1972 4
1973 2
1974 1
1975 1
1976 2
1977 3
1978 1
1979 3
1980 1
1981 1
1982 6
1983 9
1984 10
1985 8
1986 8
1987 10
1988 26
1989 15
1990 14
1991 17
1992 21
1993 11
1994 15
1995 21
1996 35
1997 27
1998 44
1999 41
2000 43
2001 28
2002 27
2003 26
2004 25
2005 17
2006 20
2007 26
2008 25
2009 22
2010 23
2011 20
2012 24
2013 34
2014 21
2015 27
2016 26
2017 23
2018 26
2019 33
2020 27
2021 40
2022 41
2023 35
2024 59
2025 44
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,048 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE Trial Investigators. Yamashita Y, et al. Among authors: kaneda k. Circulation. 2025 Mar 4;151(9):589-600. doi: 10.1161/CIRCULATIONAHA.124.072758. Epub 2024 Nov 18. Circulation. 2025. PMID: 39556015 Free PMC article. Clinical Trial.
[Preface].
Nitta A, Kaneda K. Nitta A, et al. Among authors: kaneda k. Nihon Yakurigaku Zasshi. 2020;155(3):129. doi: 10.1254/fpj.19149. Nihon Yakurigaku Zasshi. 2020. PMID: 32378627 Japanese. No abstract available.
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.
Hiromatsu Y, Ishikawa E, Kozaki A, Takahashi Y, Tanabe M, Hayashi K, Imagawa Y, Kaneda K, Mimura M, Dai X, Hayashida T, Akamizu T. Hiromatsu Y, et al. Among authors: kaneda k. Lancet Reg Health West Pac. 2025 Jan 18;55:101464. doi: 10.1016/j.lanwpc.2025.101464. eCollection 2025 Feb. Lancet Reg Health West Pac. 2025. PMID: 39896230 Free PMC article.
[Transcription Regulators and Bone Metabolism].
Hinoi E, Iezaki T, Fukasawa K, Kaneda K. Hinoi E, et al. Among authors: kaneda k. Yakugaku Zasshi. 2019;139(1):15-18. doi: 10.1248/yakushi.18-00154-1. Yakugaku Zasshi. 2019. PMID: 30606922 Free article. Review. Japanese.
Effect of concomitant use of yokukansan on steady-state blood concentrations of donepezil and risperidone in real-world clinical practice.
Saruwatari J, Kaneko T, Murata T, Narise H, Kugimoto S, Nishimura E, Tetsuka N, Ando M, Oi M, Ota M, Hamada N, Kaneda K, Furusho S, Sakamoto M, Kajiwara-Morita A, Oda K, Oniki K, Ueda K, Jono H, Yasui-Furukori N. Saruwatari J, et al. Among authors: kaneda k. Neuropsychopharmacol Rep. 2024 Sep;44(3):614-619. doi: 10.1002/npr2.12459. Epub 2024 Jul 8. Neuropsychopharmacol Rep. 2024. PMID: 38978357 Free PMC article.
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5.
Watabe T, Naka S, Shirakami Y, Kaneda K, Murakami M, Toyoshima A, Cardinale J, Giesel FL. Watabe T, et al. Among authors: kaneda k. Semin Nucl Med. 2025 Sep 30:S0001-2998(25)00120-5. doi: 10.1053/j.semnuclmed.2025.09.005. Online ahead of print. Semin Nucl Med. 2025. PMID: 41033956 Free article. Review.
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
Sueta D, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Shioyama W, Dohke T, Nishikawa R, Kimura T, Tsujita K; COMMAND VTE Registry-2 Investigators. Sueta D, et al. Among authors: kaneda k. Thromb Haemost. 2024 Nov;124(11):1013-1023. doi: 10.1055/a-2316-5269. Epub 2024 Apr 29. Thromb Haemost. 2024. PMID: 38684190
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2.
Ikeda N, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Kimura T; COMMAND VTE Registry‐2 Investigators. Ikeda N, et al. Among authors: kaneda k. J Am Heart Assoc. 2024 Nov 5;13(21):e035997. doi: 10.1161/JAHA.124.035997. Epub 2024 Oct 22. J Am Heart Assoc. 2024. PMID: 39435728 Free PMC article.
1,048 results